Using capture–recapture methods to assess varicella incidence in a community under active surveillance
Introduction
Capture–recapture methods, derived from techniques developed for studies of animal abundance, estimate the true population size by evaluating the degree of overlap among incomplete lists of cases from existing data sources. Capture–recapture involves consideration of three basic assumptions: (1) the population is closed, i.e. no significant changes occur in the population under study during the investigation (e.g. due to migration or death); (2) there is no loss of tags so that individuals can be matched from capture to recapture; and (3) each individual has the same probability of being caught in the second sample so that capture in the first sample does not affect capture in the second sample, i.e. the samples are independent. While assumptions (1) and (2) are often met, failure to meet assumption (3) can lead to inaccurate and sometimes misleading results—since in epidemiological investigations, sources often display dependence and heterogeneity of capture probabilities [1].
This is the first paper to apply capture–recapture to varicella, a common communicable disease that displays seasonality. Capture–recapture methods have been used in the 1980s and 1990s in studies to estimate the completeness and prevalence of many infectious and chronic diseases, including pertussis [2], tetanus [3], sexually transmitted disease [4], AIDS [5], [6], measles [7], [8], meningococcal disease (which is also a highly seasonal infection) [9], [10], HIV-1 [11], and cryptococcosis [12].
The major question individuals have regarding capture–recapture is “Will capture–recapture give you the ‘truth’, i.e. an extremely accurate estimate of the incidence of disease?” Simply answered, no—it will not. The estimates presented in most epidemiologic studies are extremely poor, missing 10–90% of the cases, with a high degree of variation [13], [14], [15], [16]. Therefore, the options are (a) not to use capture–recapture and report varicella cases from which incidence rates are almost uninterruptible, (b) try to count every case of varicella which is horrendously expensive and slow, or (c) utilize capture–recapture which, depending on the degree to which the assumptions are satisfied, can be a compromise, reasonably accurate, quick, and inexpensive approach.
Section snippets
Surveillance methods
The Varicella Active Surveillance Project (VASP) collected case reports of varicella from approximately 300 reporting sites representing nearly 100% sampling of the Antelope Valley population from 1 January 1995 through 31 December 1995. A case of varicella is defined as illness with acute onset of a diffuse papulovesicular rash without other known cause. Reporting sites were comprised of two main ascertainment sources: schools—consisting of all public and private schools and daycare centers
Results
Reporting completeness of varicella cases via active surveillance using two ascertainment sources was 46% with an estimated 4498 (95% CI, 4122–4962) cases in the 1–19 age group (Table 1). The NHIS annual varicella incidence in the US of 53.2 cases per 1000 in this same age group is 4.2% higher than the ascertainment-corrected incidence in the Antelope Valley of 50.9 cases per 1000 (4498/88,379) (Table 2).
Cases among individuals aged 1–19 years were stratified by quarter to evaluate the effects
Discussion
Since the Antelope Valley is a geographically isolated community in which few individuals seek healthcare or attend school outside the region, the study population is effectively closed. Cases reported to active surveillance with addresses outside the surveillance area of Antelope Valley were excluded.
Failure to identify the same individual in both the school and healthcare ascertainment sources will lead to an overestimation of varicella cases based on the assumptions of capture–recapture
Acknowledgements
We wish to thank each of the 300 surveillance sites, including school principals and nurses, as well as physicians and other healthcare professionals in the Antelope Valley community for their faithful and continued reporting of varicella cases to this project. The Varicella Active Surveillance Project under the Los Angeles County Department of Health Services (LACDHS), Acute Communicable Disease Control unit, is supported by a grant provided by the Centers for Disease Control and Prevention
References (24)
- et al.
Loglinear models using capture–recapture methods to estimate the size of a measles epidemic
J. Clin. Epidemiol.
(1996) - et al.
Capture–recapture methods (Letter)
The Lancet
(1992) Capture–recapture methods in epidemiological studies
Infect. Control Hosp. Epidemiol.
(1996)- et al.
Pertussis hospitalizations and mortality in the United States, 1985–1988
JAMA
(1992) - et al.
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979–1984
Am. J. Epidemiol.
(1990) - et al.
Using mark-recapture methodology to estimate the size of a population at risk for sexually transmitted diseases
Stat. Med.
(1992) - et al.
Evaluation of active versus passive AIDS surveillance in Oregon
Am. J. Public Health
(1990) - et al.
Review of death certificates to assess completeness of AIDS case reporting
Public Health Rep.
(1987) - et al.
Reporting efficiency during a measles outbreak in New York City, 1991
Am. J. Public Health
(1993) - et al.
Evaluation of the exhaustivness and representativeness of a surveillance system using the capture–recapture method: application of the surveillance of meningococcal infections in France in 1989 and 1990
Rev. Epidmiol. Sante Publique
(1993)
Assessment of surveillance for meningococcal disease in New York State, 1991
AJE
Capture–recapture to estimate the size of the population with human immunodeficiency virus type 1 infection
Epidemiology
Cited by (11)
Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data
2013, VaccineCitation Excerpt :Goldman secured the services of a knowledgeable attorney, who, after reviewing the facts, advised the Los Angeles County's legal counsel: “(a) if your client persists in its efforts to restrain his findings, (b) if his findings enhance the public health, safety, and welfare, (c) if by seeking to restrain him from imparting valuable information concerning the lack of safety and effectiveness of the pharmaceutical being reported upon, and (d) if the County of Los Angeles has in any way been enriched by its participation in any study the results of which it seeks to restrain in this manner or any other manner whatsoever,” then there would be follow-up litigation under both the State and Federal False Claims Acts. The county dropped its opposition and the manuscripts were peer-reviewed and accepted for publication as three consecutive articles in the journal Vaccine in October 2003 [3,31,32]. In 2004, AV-VASP and CDC took issue with Goldman's presentation of HZ data and authored a criticism [33] of the three studies published in Vaccine by Goldman.
Scientific commentary [2] (multiple letters)
2004, VaccineThe changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014
2018, Epidemiology and InfectionEstimating the undetected burden of influenza hospitalizations in children
2007, Epidemiology and InfectionVaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data
2014, Human and Experimental Toxicology